Topically applied griseofulvin in the treatment of superficial dermatomycoses in Egypt.

One-hundred and fifty-five patients suffering from T. Capitis, T. Corporis, T. Cruris and T. Verisicolor participated in studies of topically applied griseofulvin. Various concentrations of the drug were prepared in an ointment form in a new solvent system. Successful results were obtained with the 2% preparation in cases of T. Corporis, T. Cruris and T. Versicolor. Failure of the therapy was observed in cases of T. Capitis. No side-effects occurred in any patient using the 2% preparation. In the opinion of the authors, topically applied griseofulvin in the new solvent system is safe and highly effective in the treatment of superficial dermatomycoses.
AuthorsH Abdel-Aal, M EL-Shazli, A M Saleh
JournalThe Journal of international medical research (J Int Med Res) Vol. 5 Issue 5 Pg. 382-6 ( 1977) ISSN: 0300-0605 [Print] ENGLAND
PMID913867 (Publication Type: Journal Article)
Chemical References
  • Griseofulvin
  • Administration, Topical
  • Adolescent
  • Adult
  • Child
  • Dermatomycoses (drug therapy)
  • Egypt
  • Female
  • Griseofulvin (administration & dosage, therapeutic use)
  • Humans
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: